elbion AG
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) Overactive Bladder, Urinary Incontinence | Phase 2 | 2007-02-01 |
| Terminated | ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Do Panic Disorder | Phase 2 | 2006-05-01 |